Entrada Therapeutics Inc
NASDAQ:TRDA
Entrada Therapeutics Inc
NASDAQ:TRDA
Price:
5.61
USD
3.51%
Market Cap:
$217.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Entrada Therapeutics Inc
NASDAQ:TRDA
|
US |
|
S
|
SEI Investments Co
F:SI3
|
US |
|
T
|
Tesla Inc
BMV:TSLA
|
US |
|
Haier Smart Home Co Ltd
F:HAI0
|
CN |
|
E
|
Edil San Felice SpA Societa Benefit
MIL:ESF
|
IT |
|
Breakthrough Minerals Ltd
ASX:BTM
|
AU |
|
O
|
Obayashi Corp
SWB:OBA
|
JP |
|
CrowdStrike Holdings Inc
NASDAQ:CRWD
|
US |
|
B
|
Bank of the Philippine Islands
XPHS:BPI
|
PH |
|
M
|
Microchip Technology Inc
SWB:MCP
|
US |
|
U
|
UBS Group AG
SWB:0UB
|
CH |
Multiples-Based Value
The Multiples-Based Value for Entrada Therapeutics Inc (TRDA) under the Base Case is hidden
USD.
Compared with the current market price of 5.61 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TRDA Multiples-Based Value
LOCKED